Abstract:Background: The Von Hippel-Lindau (VHL) gene is a tumor-suppressor gene. Recent studies have shown that low expression of VHL has a close relationship with tumor formation, progression, and prognosis. Hypoxia-inducible factor (HIF)-1 alpha is a transcription factor, which exists universally in mammals including humans under states of hypoxia. Some studies have also shown that expression of HIF-1 alpha closely correlates with tumor progression, angiogenesis, metastasis, and invasion. This molecule is also an important cytokine, which may be used to evaluate the prognosis of some malignant tumors. In this study, we studied the expression of VHL and HIF-1 alpha and evaluated their clinicopathologic significance and relationship in benign and malignant lesions of the gallbladder.Methods: EnVision immunohistochemistry was used for detecting the expression level of VHL and HIF-1 alpha in routinely paraffin-embedded sections from specimens of gallbladder adenocarcinoma (n = 108), peritumoral tissues (n = 46), adenomatous polyps (n = 15), and chronic cholecystitis (n = 35).Results: The frequency of positive VHL expression was significantly lower in adenocarcinoma of gallbladder (48.1%) than that in peritumoral tissues (80.4%), adenomatous polyps (80.0%), and chronic cholecystitis (88.6%) (P < 0.05 or P < 0.01). In contrast, the positive HIF-1 alpha expression was significantly higher in adenocarcinoma (53.7%) than that in peritumoral tissues (34.8%), adenomatous polyps (26.7%), and chronic cholecystitis (14.3%) (P < 0.05 or P < 0.01). The benign lesions with positive VHL and/or negative HIF-1 alpha expression showed atypical hyperplasia in gallbladder epithelium. The positive expression of VHL and negative expression of HIF-1 alpha were significantly associated with differentiation, tumor mass, lymph node metastasis, and invasion of adenocarcinoma (P < 0.05 or P < 0.01). The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder adenocarcinoma was found P < 0.01). Univariate Kaplan-Meier analysis showed that elevated expression of VHL (P = 0.023) or lowered expression of HIF-1 alpha (P = 0.020) was closely associated with decreased overall survival. Multivariate Cox regression analysis showed that positive expression of VHL (P = 0.013) and/or negative expression of HIF-1 alpha (P = 0.005) was an independent poor-prognostic predictor in gallbladder adenocarcinoma.Conclusions: The lowered expression of HIF-1 alpha and elevated expression of VHL in gallbladder adenocarcinoma are important markers for the progression, clinical biological behavior, and prognosis. Measurement of VHL and HIF-1 alpha expression could be a tool for early detection of gallbladder cancer in benign lesions and in population screening. The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder may require further study to see whether they are intrinsically related.

Clinicopathological Significance of DNA Fragmentation Factor 45 and Thyroid Transcription Factor 1 Expression in Benign and Malignant Lesions of the Gallbladder.

Clinicopathologic Significance of Minichromosome Maintenance Protein 2 and Tat-interacting Protein 30 Expression in Benign and Malignant Lesions of the Gallbladder

Expression of CDC6 and GDF-9 and Their Clinicopathological Significances in Benign and Malignant Lesions of the Gallbladder.

Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder

Expression of pGSK-3α/β (Tyr279/216) and XIAP proteins in cholangiocarcinoma and their clinical significance

Expression of ABCG2, SFRP2, BRMS1 and HPA in Benign and Malignant Lesions of the Gallbladder and Their Clinicopathological Significances

Identification of PEG10 and TSG101 as Carcinogenesis, Progression, and Poor-Prognosis Related Biomarkers for Gallbladder Adenocarcinoma

Expressions of GRP78 and GRP94 in the benign and malignant lesions of gallbladder and their clinicopathological significance

The Clinicopathological Significance of Jagged1 and DLL4 in Gallbladder Cancer.

NT5E and FcGBP as key regulators of TGF-1-induced epithelial–mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer

Expression of Cdx2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

Expression of Formin-like 2 and Cortactin in Gallbladder Adenocarcinoma and Their Clinical Significance

Study on the expression of GSCs marker and it′s regulated factor in benign and malignant gallbladder lesions

Expressions and Clinical Significance of TGF-β1, MMP-2 in Gallbladder Carcinoma

Expression and clinical significance of ABCG2 and OCT4 in gallbladder carcinoma tissues

Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma

Expressions of Farnesoid X Receptor and Myeloid Cell Leukemia Sequence 1 Protein Are Associated with Poor Prognosis in Patients with Gallbladder Cancer.

Identification of Cd146 Expression, Angiogenesis, and Lymphangiogenesis As Progression, Metastasis, and Poor-Prognosis Related Markers for Gallbladder Adenocarcinoma

Expression of DNApkcs and Ku70 in Benign and Malignant Lesions of Gallbladder and Its Clinicopathological Significance

Clinicopathological Features and CCT2 and PDIA2 Expression in Gallbladder Squamous/adenosquamous Carcinoma and Gallbladder Adenocarcinoma

Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer